LOS ANGELES — The definition of seizure clusters varies significantly across epilepsy monitoring units (EMUs), according to a new survey of expert opinion. The findings should prompt the development ...
Patients treated with 5-mg midazolam nasal spray were more likely than those given placebo to remain seizure free for 6 hours after treatment or have their seizure terminated within 10 minutes, with ...
SAN DIEGO, Dec. 6, 2024 /PRNewswire/ -- Neurelis, Inc., today announced details of its presentations at the American Epilepsy Society (AES) Annual Meeting to be held December 6-10 in Los Angeles. The ...
San Diego, California — It's still early days, but brand-new formulations of rescue benzodiazepine could be in store for patients who have acute repetitive seizures (ARS). Promising phase 3 trial ...
(RTTNews) - Aquestive Therapeutics, Inc. (AQST), a pharmaceutical company focused on delivering innovative medicines, announced that the FDA has granted Orphan Drug Exclusivity to Libervant (diazepam) ...
The Phase 3 open-label extension (OLE) study evaluated the safety of repeated, intermittent use of NAYZILAM in individuals living with epilepsy experiencing acute repetitive seizures, also known as ...
Valtoco (diazepam) is a prescription drug that’s used to treat seizure clusters in adults and certain children. Valtoco comes as a nasal spray. Valtoco contains the active ingredient diazepam. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback